While McAlpine has reported cases like these to Sahpra, he says the paperwork puts many doctors off, and the limited number of adverse events recorded by the regulator is almost certainly the tip of the iceberg
The troubleshooting guide for tirzepatide weight loss plateaus covers common causes, but a prescriber can run bloodwork and assess factors that self-evaluation cannot
2024;doi:10.1056/NEJMoa2401943) and survodutide (Boehringer Ingelheim
The current state of peptide drug discovery: back to the future
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus
These sources were used to collect prescription statistics, regulatory approval data, clinical safety studies, epidemiological trends, and competitive landscape analysis for short-acting GLP-1 agonists, long-acting GLP-1 agonists, dual-action therapies, and emerging oral/inhalation formulations